Table 4 Characteristics of participants and the baseline of function status before the experiment
Characteristics | VR group | CT group | Baseline function status | VR group | CT group | Between group p-value |
|---|---|---|---|---|---|---|
Age in years/median | 74 (63–79) | 83.5 (72–85) | FMA-UE |  |  |  |
Stroke in years/median | 2 (1–4) | 2 (2–6) |  Upper extremity | 31 (26.5–34) | 35.5 (30–36) | 0.076 |
Gender |  |  |  Wrist | 9 (6–10) | 10 (5–11) | 0.116 |
 Female, n(%) | 3 (20) | 2 (13.33) |  Hand | 13 (11–14) | 13 (10–14) | 0.306 |
 Male, n(%) | 4 (26.7) | 6 (40) |  Coordination | 4 (3.5–6) | 5(3.5–6) | 0.306 |
Comorbidities |  |  |  Total | 59 (48–61) | 64 (50–65) | 0.076 |
 Hypertension, n(%) | 7 (46.67) | 7 (46.67) | WMFT |  |  |  |
 Diabetes Mellitus, n(%) | 5 (33.33) | 1 (6.67) |  FAS | 69 (63.5–71.5) | 72.5 (57–74.5) | 0.14 |
 Dyslipidemia, n(%) | 6 (40) | 3 (20) |  Time in seconds | 3.24 (2.71–3.45) | 2.78 (1.61–3.385) | 0.23 |
 Atrial fibrillation, n(%) | 0 | 2 (13.33) | SRMS | 26 (22–27.5) | 23 (20.5–23.5) | 0.076 |
Stroke type | Â | Â | ROM in degree | Â | Â | Â |
 Ischaemic, n(%) | 6 (40) | 7 (46.67) |  Shoulder flexion | 130 (110–132.5) | 130 (110–132.5) | 0.477 |
 Haemorrhagic, n(%) | 1 (6.67) | 1 (6.67) |  Shoulder horizontal Abduction | 20 (10–23.5) | 20 (10–23.5) | 0.168 |
Affected side |  |  |  Shoulder horizontal Adduction | 95 (77–97) | 95 (77–97) | 0.116 |
 Right, n(%) | 0 | 1 (6.67) |  |  |  |  |
 Left, n(%) | 7 (46.67) | 7 (46.67) |  |  |  |  |